| OPEN-LABEL PLACEBO reflections on a research agenda |
20 |
| THE US DIRECT-TO-CONSUMER MARKETPLACE FOR AUTOLOGOUS STEM CELL, INTERVENTIONS |
12 |
| SPINNING THE GENOME why science hype matters |
7 |
| THE MEANING RESPONSE, PLACEBO, AND METHODS |
7 |
| HOPE IN MEDICINE applying multidisciplinary insights |
7 |
| THE PLACEBO PHENOMENON a narrow focus on psychological models |
6 |
| REDUCTIONISM, ORGANICISM, AND CAUSALITY IN THE BIOMEDICAL SCIENCES |
6 |
| THE NEW SCIENCE OF PRACTICAL WISDOM |
5 |
| THREE PROBLEMS WITH BIG DATA AND ARTIFICIAL INTELLIGENCE IN MEDICINE |
4 |
| CHALLENGES IN THE REGULATION OF AUTOLOGOUS STEM CELL INTERVENTIONS IN THE UNITED STATES |
3 |
| THE TENSION BETWEEN BIG DATA AND THEORY IN THE OMICS ERA OF BIOMEDICAL RESEARCH |
3 |
| CONSCIENTIOUS OBJECTION, MORAL INTEGRITY, AND PROFESSIONAL OBLIGATIONS |
3 |
| CONSENSUS IN PLACEBO STUDIES lessons from the philosophy of science |
3 |
| A CRITICAL (AND CAUTIOUSLY OPTIMISTIC) APPRAISAL OF MOERMAN'S MEANING RESPONSE |
2 |
| 200 YEARS AFTER FRANKENSTEIN |
2 |
| INTEGRITY IN ACTION medical education as a training in conscience |
2 |
| GENETIC POINTILLISM VERSUS PHYSIOLOGICAL FORM |
2 |
| PERSONALIZED, PRECISION, AND N-OF-ONE MEDICINE a clarification of terminology and concepts |
2 |
| WHAT IS CANCER? |
2 |
| CONTROL OF CARDIOVASCULAR DISEASE IN THE 20TH CENTURY meeting the challenge of chronic degenerative disease |
1 |
| HUMAN MOLECULAR GENETICS HAS NOT YET CONTRIBUTED TO MEASURABLE PUBLIC HEALTH ADVANCES |
1 |
| REINING IN THE PLACEBO EFFECT |
1 |
| MEANING AND AN OVERVIEW OF THE PLACEBO EFFECT |
1 |
| THE RISE AND FALL OF THE PERSONAL EQUATION IN AMERICAN AND BRITISH MEDICINE, 1855-1952 |
1 |
| ON COLLABORATION IN BIOETHICS SCHOLARSHIP |
1 |
| THE ROLE OF PHYSICIANS DURING HUNGER STRIKES OF UNDOCUMENTED MIGRANT WORKERS IN A NON-CUSTODIAL SETTING |
1 |
| ALTERNATIVES TO WAR WITHIN MEDICINE from conscientious objection to nonviolent conflict about contested medical practices |
1 |
| UNDERSTANDING CONSCIENCE AS INTEGRITY why some physicians will not refer patients for ethically controversial practices |
1 |
| CONSCIENCE, MORAL REASONING, AND SKEPTICISM |
1 |
| CONSCIENCE AND THE WAY OF MEDICINE |
1 |
| GLOBAL BIOETHICS a story of dreams and doubts from Bengal |
1 |
| PUBLIC FUNDING FOR GENOMICS AND THE RETURN ON INVESTMENT a public health perspective |
1 |
| INFERTILITY COMICS AND GRAPHIC MEDICINE |
1 |
| WHAT-IF ANYTHING-SETS LIMITS TO THE CLINICAL ETHICS CONSULTANT'S EXPERTISE? |
1 |
| CREDIT AND PRIORITY IN SCIENTIFIC DISCOVERY |
1 |
| VULNERABILITIES AND THE USE OF AUTOLOGOUS STEM CELLS FOR MEDICAL CONDITIONS IN AUSTRALIA |
1 |
| THE NEED FOR BENEFICENCE AND PRUDENCE IN CLINICAL INNOVATION WITH AUTOLOGOUS STEM CELLS |
1 |
| BETWEEN THE LOCAL AND THE GLOBAL evaluating European regulation of stem cell regenerative medicine |
1 |
| I SLEEP, BUT MY HEART IS AWAKE: negotiating marginal states in life and death |
1 |
| OFF THE CHARTS medical documentation and selective redaction in the age of transparency |
1 |
| VIRTUE, VICE, AND VORACIOUS SCIENCE how should we approach the ethics of primate research? |
1 |
| JOINING THE CLUB |
1 |
| THERE IS NO OBSTETRICAL DILEMMA towards a braver medicine with fewer childbirth interventions |
1 |
| FROSTED INTELLECTUALS how Dr. Leo Kanner constructed the autistic family |
1 |
| FRANKENSTEIN AS CAUTIONARY TALE FOR MEDICAL HUMANITIES? a brief coda |
0 |
| CARE LABOR IN VAD THERAPY some feminist concerns |
0 |
| HEURISTICS AND EXPLANATION IN TRANSLATIONAL MEDICINE |
0 |
| THE CHALLENGE OF MUTUAL DISCLOSURE IN GLOBAL HEALTH PARTNERSHIPS |
0 |
| SHOULD THE EUTHANASIA ACT IN BELGIUM INCLUDE MINORS? |
0 |
| HUMANITY AND ORDINARY ABUSE learning from hospital patients' letters of complaint |
0 |
